CRL Stock Analysis: Buy, Sell, or Hold?
CRL - Charles River Laboratories International, Inc.
$210.48
-1.20 (-0.57%)
▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 18, 2026
16d
Get Alerted When CRL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CRL shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: CRL shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$263.34
Based on 5.5% avg growth
INTRINSIC VALUE TODAY
$163.51
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CRL is currently trading at $210.48, which is considered fair relative to its 30-day fair value range of $205.88 to $221.90. The stock's valuation (Forward PE: 19.2) is in line with its historical norms (18.4). At these levels, the market is pricing in 1.5% annual earnings growth.
Technical Outlook: Technically, CRL is in a strong uptrend. The price is currently testing key support at $208.11. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CRL is in a strong uptrend. The price is currently testing key support at $208.11. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$205.88 -
$221.90
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
76.5%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($215.73)
- BULLISH: Expecting earnings turnaround to 1.5% growth with -0.5% revenue growth
Fair Price Analysis
30-Day Fair Range
$205.88 -
$221.90
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$12.22
(5.8%)
Support & Resistance Levels
Support Level
$208.11
Resistance Level
$228.39
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
19.22
Wall Street Target
$215.73
(+2.5%)
Revenue Growth (YoY)
-0.5%
Earnings Growth (YoY)
-17.3%
Profit Margin
-2.1%
Valuation Premium vs History
+1.5% premium
PE vs Historical
19.2 vs 18.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.5%
(market-implied from PE analysis)
1-Year Target
$213.64
(+2%)
2-Year Target
$216.84
(+3%)
3-Year Target
$220.09
(+5%)
3-Yr Target (if PE normalizes)
(PE: 19→18)
PE COMPRESSION
$210.75
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 7.0%)
$298.93
(+42%)
Base:
(SPY PE: 19.2, Growth: 7.0%)
$257.58
(+22%)
Bear:
(PE: 16.3, Growth: 7.0%)
$218.95
(+4%)
Last updated: January 31, 2026 9:51 PM ET
Data refreshes hourly during market hours. Next update: 10:51 PM
Data refreshes hourly during market hours. Next update: 10:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Joseph W Laplume
SELL
800 shares
2025-08-18
Joseph W Laplume
SELL
400 shares
2025-08-07
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 47 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 57 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$121 | 62 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$263 | 47 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$257 | 58 HOLD |
Advanced CRL Option Strategies
Professional options setups generated by AI based on today's CRL price and gamma walls.
